19 related articles for article (PubMed ID: 38622522)
1. Clinical implications and mechanism of CST1 in gastric carcinoma based on database screening.
Liu P; Luan J; Peng X; Zhang X; Zhang J; Chang H
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):184-189. PubMed ID: 38814219
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.
Liu S; Wang Z; Hu L; Ye C; Zhang X; Zhu Z; Li J; Shen Q
Transl Oncol; 2024 Jul; 45():101982. PubMed ID: 38718436
[TBL] [Abstract][Full Text] [Related]
3. Expression and Clinical Significance of ILF2 in Gastric Cancer.
Yin ZH; Jiang XW; Shi WB; Gui QL; Yu DF
Dis Markers; 2017; 2017():4387081. PubMed ID: 28831206
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
5. Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Liu JY; Dong XX; Lu JN; Zhang Y; Liu KF; Liu LF; E QZ; Lu XJ; Yin JY; Shen YP
FEBS Open Bio; 2019 Jan; 9(1):35-42. PubMed ID: 30652072
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
8. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
[TBL] [Abstract][Full Text] [Related]
9. Deciphering gastric inflammation-induced tumorigenesis through multi-omics data and AI methods.
Zhang Q; Yang M; Zhang P; Wu B; Wei X; Li S
Cancer Biol Med; 2023 Aug; 21(4):312-30. PubMed ID: 37589244
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
